4 大 1st-line TB drugs (RIPE); 2nd-line (FQ, aminoglycoside, bedaquiline, pretomanid, linezolid, delamanid, cycloserine etc.); 22E TB Tx: 2024 WHO 4-month rifapentine-moxifloxacin regimen for non-cavitary smear-neg + BPaL/BPaLM for MDR/XDR。